Skip to content
value.today

MedMen: financial analysis

Ratios worked out from 3 fiscal years of MedMen's statements.

The newest statement on file is for fiscal 2021. The figures below describe that year, not MedMen today.

Operating margin, 2021
-120.0%
Return on equity, 2021
119.9%
Free cash flow margin, 2021
-50.8%

MedMen scorecard#

Passes 3 of the 5 checks that could be worked out. Fiscal year 2021.

  • Valuationnot known
    • –P/E below its peers' medianNo market cap.
    • –Price to book below its peers' medianNo market cap.
    • –Price to sales below its peers' medianNo market cap.
    • –Free cash flow yield above 5%No market cap.
    • –Earnings yield above the 10-year Treasury yieldNo market cap.
    • –The price assumes slower growth than the last three years'No market cap.
  • Growth1 of 1
    • ✓Revenue grew in the newest year6.5%Revenue up 6.5% in fiscal 2021.
    • –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
    • –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
    • –Earnings per share grew in the newest yearEarnings per share of two years are not on file.
    • –Net income higher than five years earlierNet income of five years earlier is not on file.
    • –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
  • Profitability2 of 2
    • ✓Profitable in the newest year$211 MNet income $211 M in fiscal 2021.
    • –Profitable in each of the last five yearsFive years of net income are not on file.
    • –Operating margin above its peers' medianToo few peers for a median.
    • ✓Return on equity above 15%119.9%119.9% in fiscal 2021.
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial health0 of 2
    • ✗Short-term assets cover short-term liabilities0.5×Current ratio 0.51 at the end of fiscal 2021.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2021.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returnsnot known
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • –Share count up no more than 2% in a yearShare counts of two years are not on file.
    • –Dividends and buybacks above 3% of the market valueNo market cap.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (sec), the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

What the 2021 statements show#

Each line is an observation with its numbers, not a judgement of the company.

Worth a look

  • Free cash flow was negative: -$72 million.
  • Only -30% of net income arrived as cash from operations.
  • Liabilities due within a year exceed current assets (current ratio 0.51).

Piotroski F-score

Nine yes/no tests of whether the company's finances improved in the year. One point each.

5of 7(2 of the nine tests cannot be worked out from the statements on file, so there is no full score)
  • Made a profityes
  • Operations brought in cashno
  • Return on assets roseyes
  • Cash from operations exceeds profitno
  • Long-term debt fell against assetsnot on file
  • Current ratio roseyes
  • No new shares issuednot on file
  • Gross margin roseyes
  • Asset turnover roseyes

Where the return on equity comes from

The DuPont split: margin, times how hard the assets work, times how much of them is financed by others.

Net margin149.8%Asset turnover0.36×Assets to equity2.22×Return on equity119.9%

Profitability#

MedMen: profitability by fiscal year
Fiscal yearTrend202120202019
Gross margin49.5%45.9%35.6%
Operating margin-120.0%-41.7%-278.4%
Net margin149.8%119.2%339.1%
Return on equity119.9%——
Return on assets53.2%30.1%91.7%

Growth#

MedMen: growth by fiscal year
Fiscal yearTrend202120202019
Revenue growth6.5%-14.8%—
Net income growth33.8%-70.1%—

Financial strength#

MedMen: financial strength by fiscal year
Fiscal yearTrend202120202019
Current ratio0.51×0.51×0.40×
Equity share of assets49.9%40.6%-30.8%

Cash#

MedMen: cash by fiscal year
Fiscal yearTrend202120202019
Free cash flow$-72 M$-62 M$-167 M
Free cash flow margin-50.8%-47.0%-107.6%
Cash conversion-29.7%-37.7%-20.8%
Capital spending share of revenue6.4%2.0%37.0%

Efficiency#

MedMen: efficiency by fiscal year
Fiscal yearTrend202120202019
Asset turnover0.36×0.25×0.27×

How each figure is worked out#

Gross margin
Gross profit as a share of revenue.
Operating margin
Operating income as a share of revenue.
Net margin
Net income as a share of revenue.
Return on equity
Net income as a share of shareholders' equity (the average of the start and the end of the year). Not given when equity is negative.
Return on assets
Net income as a share of total assets (average of the year).
Revenue growth
Revenue against the year before.
Net income growth
Net income against the year before. Only when both years were profitable.
Current ratio
Assets due within a year divided by liabilities due within a year.
Equity share of assets
Shareholders' equity as a share of total assets.
Free cash flow
Cash from operations less capital spending.
Free cash flow margin
Free cash flow as a share of revenue.
Cash conversion
Cash from operations as a share of net income. Only when the year was profitable.
Capital spending share of revenue
Capital spending as a share of revenue.
Asset turnover
Revenue divided by total assets (average of the year).

Source: MedMen's statements: annual reports filed with the SEC. Arithmetic on reported figures, in US dollars; nothing is estimated. A figure is blank when a line it needs is not in the statements on file, and left out when the result cannot be right (a margin from next to no revenue). yields use today's market value. Medians for every industry · Back to MedMen